The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,760.00
Bid: 3,785.00
Ask: 3,795.00
Change: 25.00 (0.67%)
Spread: 10.00 (0.264%)
Open: 3,755.00
High: 3,795.00
Low: 3,735.00
Prev. Close: 3,735.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 2023 Trading Update

31 Oct 2023 07:00

RNS Number : 7753R
RHI Magnesita N.V.
31 October 2023
 

RHI Magnesita N.V.

("RHI Magnesita" the "Company" or the "Group")

Q3 2023 TRADING UPDATE

 

RHI Magnesita, the leading global supplier of high?grade refractory products, systems and solutions, today provides an update on trading for the three months to 30 September 2023 ('Q3').

Q3 trading

Adjusted EBITA in the third quarter was at a similar level to that achieved in Q1 and Q2, as resilient pricing, the benefits of strategic initiatives and M&A offset lower sales volumes and under-absorption of fixed costs. The Group has also achieved a consistent improvement in its operating KPIs in the year to date, leading to improved customer service levels and more effective cost management.

Volume performance in Q3 reflected normal seasonal factors, with plants operating at an average of 70% of capacity, and was consistent with the expectation underpinning previous guidance for full year sales volumes (pre M&A) to be up to 5% below 2022. Steel volume weakness was most pronounced in Europe, China and South America, reflecting local market conditions.

Pricing was strongest in the cement & lime and nonferrous metals segments within the Industrials business, due to the later cycle nature of these customer industries. Refractory raw material prices moved lower in Q3, indicating potential for finished goods pricing pressure in Q4.

The Group's EBITA margin in Q3 reduced slightly to 11.2%, from 11.6% in H1 2023. Refractory margin remained strong with a relatively low contribution from vertical integration at 1.8%, as guided.

Financial position

The Group continued to generate strong organic operating cash flows from its base business before M&A with YTD cash conversion increasing to over 120% due to further release of working capital.

M&A has increased net debt by approximately ?430 million in the year to date, including working capital, assumed net debt and the P-D Refractories transaction completed in October. Acquisitions in India were partially funded by the issuance of 27 million shares in RHI Magnesita India Limited to the sellers of Dalmia OCL and a Qualified Institutional Placement raising ?100 million in April 2023. The Group's gearing measured as a ratio of net debt to EBITDA is expected to increase modestly by the year end, but to remain in line with the target range of 2.0-2.5x.

M&A update

On 3 October 2023, the Group completed its acquisition of P-D Refractories, a European producer of high quality alumina-based refractories for industrial applications in process industries, with revenues of ?171 million in the year to 31 December 2022. The transaction is not expected to result in a material increase in gearing for the Group on a pro forma EBITDA basis.

The Group has now completed a total of nine acquisitions in the last 24 months, as it executes on its strategy to consolidate small and medium sized businesses in its target geographies and product segments.

Outlook

Order book visibility is at normal levels with limited signs of a recovery in demand volumes in 2024, as global construction activity continues to be weak and demand in the autos market remains below pre-pandemic levels. 

However, following good execution, the strong EBITA delivered in the third quarter, outperformance in the delivery of M&A synergies in the year to date and seasonally higher volumes in cement and lime anticipated in Q4, Adjusted EBITA guidance for the full year is increased from ?360 million to at least ?380 million. The benefits from M&A and operational efficiencies will support earnings into 2024, offsetting weak demand.

Net financial expenses excluding foreign exchange related items are tracking in line with guidance of c.?65 million for 2023. Taking into account the higher EBITA forecast offset by higher financial expenses and foreign exchange adjustments in the year to date, EPS is expected to be moderately ahead of analyst consensus for the full year.

 

Stefan Borgas, Chief Executive Officer, said: "I am pleased by the strong execution demonstrated by RHI Magnesita during difficult conditions for our key end markets. We are currently benefitting from the strategic investments we have made in reducing our cost base and rationalizing our production network, together with improved planning and careful management of our assets through this period of weaker demand. Pricing discipline has helped to maintain EBITA margins at over 11%, offsetting the impact of lower production on our fixed cost base. We have also been able to progress our M&A strategy, with six acquisitions completed in the first nine months of 2023 and a total of nine in the last 24 months. As a result of success in the early stages of M&A integration and our consistent operational and financial delivery in the year to date, we are able to increase our EBITA guidance for 2023 to at least ?380 million."

 

Conference Call

A conference call will be hosted at 8:15am UK time to discuss the trading update:

Dial in

+44 207 107 0613

Access code

42809281

Webcast and playback facility

LINK

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel +43 699 1870 6490

E?mail: chris.bucknall@rhimagnesita.com

 

Media:

Hudson Sandler

Mark Garraway, Emily Dillon, Nick Moore

Tel +44 020 7796 4133

E-mail: rhimagnesita@hudsonsandler.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 15,000 employees in 47 production sites, 7 recycling facilities and more than 70 sales offices. RHI Magnesita intends to build on its leadership in revenue, scale, product portfolio and diversified geographic presence to expand further in high growth markets.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMMBMTMTIJTRJ
Date   Source Headline
13th Aug 20196:00 pmRNSTransaction in Own Shares
13th Aug 20197:00 amRNSInterim dividend - Correction of record date
12th Aug 20196:00 pmRNSTransaction in Own Shares
12th Aug 20197:05 amRNSPurchase of own shares
12th Aug 20197:00 amRNSHalf-year Report
12th Jul 20195:35 pmRNSNotice of Results
9th Jul 201910:46 amRNSExternal Directorship
9th Jul 20197:00 amRNSResult of Secondary Placing in RHI Magnesita N.V.
8th Jul 20194:37 pmRNSProposed Secondary Placing in RHI Magnesita N.V.
6th Jun 20193:22 pmRNSResult of AGM
8th May 20197:00 amRNSQ1 2019 TRADING UPDATE
7th May 20199:29 amRNSExternal Directorship
1st May 20196:00 pmRNSTotal Voting Rights
18th Apr 201912:08 pmRNSExternal Directorship
10th Apr 201911:20 amRNSMerger Update
1st Apr 201910:37 amRNSTotal Voting Rights
27th Mar 20199:34 amRNSSecondary listing on Vienna Stock Exchange
27th Mar 20197:00 amRNSFinal Results
20th Mar 201910:04 amRNSMerger Update
6th Mar 201910:27 amRNSNotice of Results
28th Feb 20194:03 pmRNSTotal Voting Rights
21st Feb 201910:35 amRNSMerger Update
14th Feb 20196:12 pmRNSNotification of Agreement
31st Jan 20195:44 pmRNSTotal Voting Rights
25th Jan 20196:00 pmRNSRHI Magnesita
24th Jan 20197:00 amRNSCancellation of Listing
22nd Jan 201911:36 amRNSMerger Update
22nd Jan 201911:21 amRNSResignation of Director
10th Jan 201912:18 pmRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
17th Dec 201812:16 pmRNSAdditional Listing
12th Dec 20185:46 pmRNSRHI Magnesita
12th Dec 20184:45 pmRNSDirector/PDMR Shareholding
11th Dec 201812:23 pmRNSBlock Listing Application
11th Dec 20187:00 amRNSMerger Update
3rd Dec 201810:12 amRNSDirector/PDMR Shareholding
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSSite Visit Presentation
27th Nov 20185:50 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSMerger Update
5th Nov 20187:01 amRNS3rd Quarter Results
2nd Nov 201811:29 amRNSChange of Corporate Broker
21st Sep 201811:21 amRNSUpdate on position of Chief Financial Officer
16th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSNew Term Loan and Multi-currency Credit Facility
1st Aug 20189:07 amRNSNotification under Listing Rule 9.6.14R
1st Aug 20187:00 amRNSProposed merger of Indian subsidiaries
29th Jun 20182:46 pmRNSDirector/PDMR Shareholding
29th Jun 20182:43 pmRNSDirector/PDMR Shareholding
29th Jun 20182:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.